Skip to main content
Clinical Trials/NCT04545372
NCT04545372
Completed
Not Applicable

Effect of Aerobic Exercises on Immune System in Patients With Multiple Sclerosis

South Valley University1 site in 1 country30 target enrollmentFebruary 2, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Multiple Sclerosis, Primary Progressive
Sponsor
South Valley University
Enrollment
30
Locations
1
Primary Endpoint
blood analysis
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) .It is the most common neurological disorders affecting young adults.Multiple sclerosis is an autoimmune disease that results in progressive neural degeneration. Cytokines play an important role in the pathogenesis and treatment of MS.

Detailed Description

This research aims to evaluate the effect of aerobic exercises on the immune system anti-inflammatory (IL-10) and pro inflammatory (IL-17) cytokines and its consequences on the functional status in the Multiple Sclerosis patients. Aerobic exercises are a term to describe planned, structured and repetitive physical activity undertaken over a prolonged period to maintain or improve physical fitness and functional capacity .

Registry
clinicaltrials.gov
Start Date
February 2, 2015
End Date
August 6, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nehad Ahmed Youness Abo-zaid

Lecturer of physical therapy

South Valley University

Eligibility Criteria

Inclusion Criteria

  • age ranged from 25 to 45 years. All the patients were remitting relapsing MS according to (revised McDonald criteria.
  • Duration of MS disease was one to two years before starting of the study. Last attack occurred three months ago. All patients were able to ambulate

Exclusion Criteria

  • Patients with other neurological deficits , patient with significant orthopedic abnormalities for both lower limbs, patient with contracture , patient with deformities, pregnant females

Outcomes

Primary Outcomes

blood analysis

Time Frame: pro inflammatory cytokine IL-17 will be assessed at 90 day

pro inflammatory cytokine IL-17

Study Sites (1)

Loading locations...

Similar Trials